Chegg receives NYSE notice of minimum share-price non-compliance
Chegg was notified by the New York Stock Exchange on July 24, 2026, that it failed to maintain compliance with the minimum share-price requirement under Section 802.01C of the NYSE Listed Company Manual, as the average closing share price of its common stock was less than $1.00 over a consecutive 30 trading-day period ending July 23, 2026. The company has a six-month cure period to regain compliance and may pursue a reverse stock split if approved by its board. The stock will continue to trade on the NYSE during the cure period, but if compliance is not restored, the company's common stock will be subject to NYSE suspension and delisting procedures.
- Average closing share price was less than $1.00 over a consecutive 30 trading-day period ending on July 23, 2026
- Company has six months to regain compliance from receipt of the July 24, 2026 notice
- This is separate from a December 2025 NYSE minimum share price notice that the company cured by the end of May 2026
- Company may effect a reverse stock split, subject to board approval, to regain compliance
- Compliance can be restored if on the last trading day of any calendar month during the cure period the stock has a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30 trading-day period ending on that day
- Stock will continue to trade on the NYSE during the cure period subject to compliance with other NYSE listing standards
Chegg faces a second minimum share-price deficiency in eight months; failure to cure within six months will trigger NYSE suspension and delisting procedures, which would force removal of the company's stock from the exchange.
Derived from 8-K filed 2026-07-24. Not investment advice. Figures are extracted from the filing; prose is AI-assisted. View the source filing on SEC.gov →